Toshifumi Ito Selected Research

Toshifumi Ito Research Topics

Disease

9	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 06/2006
8	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 06/2006
8	Chronic Hepatitis C 10/2016 - 05/2009
6	Neoplasms (Cancer) 03/2022 - 06/2006
5	Infections 05/2021 - 05/2012
5	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018 - 06/2006
4	Fibrosis (Cirrhosis) 10/2022 - 05/2012
4	Chronic Pancreatitis 12/2018 - 05/2008
3	Disease Progression 05/2021 - 06/2014
2	Liver Diseases (Liver Disease) 05/2020 - 05/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 06/2006
2	Neoplasm Metastasis (Metastasis) 08/2017 - 09/2014
2	Carcinogenesis 05/2012 - 05/2009
2	Chronic Hepatitis (Chronic Active Hepatitis) 05/2012 - 05/2009
1	Portal Hypertension 09/2020
1	Duodenal Neoplasms (Duodenal Cancer) 12/2018
1	Bile Duct Neoplasms (Bile Duct Cancer) 12/2018
1	Hypoalbuminemia 05/2018
1	Ascites 05/2018
1	Hepatic Encephalopathy 05/2018
1	Edema (Dropsy) 05/2018
1	Esophageal Neoplasms (Esophageal Cancer) 03/2018
1	Cicatrix (Scar) 03/2018
1	Ulcer 03/2018
1	Hyperbilirubinemia 03/2016
1	Hemorrhage 10/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Hyperammonemia 11/2014
1	Hepatitis B 05/2012
1	Pneumoperitoneum 01/2012
1	Colonic Neoplasms (Colon Cancer) 06/2006
1	Ulcerative Colitis 02/2002
1	Inflammation (Inflammations) 02/2002

Drug/Important Bio-Agent (IBA)

8	Ribavirin (Virazole)FDA LinkGeneric 10/2016 - 05/2009
7	InterferonsIBA 10/2016 - 05/2009
5	ZincIBA 05/2020 - 04/2013
5	Tumor Biomarkers (Tumor Markers)IBA 08/2017 - 06/2006
3	SimeprevirIBA 07/2017 - 03/2016
3	HaptoglobinsIBA 03/2016 - 06/2006
2	Antiviral Agents (Antivirals)IBA 10/2022 - 05/2021
2	Fetal Proteins (Fetoprotein)IBA 03/2022 - 07/2014
2	AlbuminsIBA 09/2020 - 05/2020
2	BilirubinIBA 09/2020 - 03/2016
2	Zinc Acetate FDA Link 05/2020 - 11/2014
2	Polysaccharides (Glycans)IBA 12/2018 - 05/2008
2	AntigensIBA 12/2018 - 01/2015
2	DiureticsIBA 05/2018 - 04/2013
2	Branched-Chain Amino AcidsIBA 05/2018 - 06/2014
2	Biomarkers (Surrogate Marker)IBA 05/2016 - 01/2015
2	Amino Acids FDA Link 01/2015 - 06/2014
1	atezolizumabIBA 03/2022
1	Bevacizumab (Avastin)FDA Link 03/2022
1	Immune Checkpoint InhibitorsIBA 03/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2022
1	lenvatinibIBA 09/2020
1	CeruletideIBA 12/2018
1	16S Ribosomal RNAIBA 12/2018
1	lipoteichoic acidIBA 12/2018
1	CytokinesIBA 12/2018
1	AntibodiesIBA 12/2018
1	Indicators and Reagents (Reagents)IBA 05/2018
1	NitrogenIBA 05/2018
1	telaprevirIBA 07/2017
1	Carrier Proteins (Binding Protein)IBA 05/2016
1	PyrophosphatasesIBA 03/2016
1	Inosine Triphosphate (ITP)IBA 03/2016
1	Leucine (L-Leucine)FDA Link 01/2015
1	CarbohydratesIBA 01/2015
1	Plant Preparations (Preparation, Plant)IBA 09/2014
1	Hepatitis B e AntigensIBA 05/2012
1	NucleotidesIBA 05/2012
1	lipoarabinomannan (LAM)IBA 05/2012
1	DNA (Deoxyribonucleic Acid)IBA 05/2012
1	Lamivudine (Epivir)FDA Link 05/2012
1	Pharmaceutical PreparationsIBA 03/2012
1	RNA (Ribonucleic Acid)IBA 03/2012
1	peginterferon alfa-2b (Pegintron)FDA Link 04/2011
1	LectinsIBA 06/2006
1	OligosaccharidesIBA 06/2006
1	Proteins (Proteins, Gene)FDA Link 06/2006
1	A-factor (Streptomyces)IBA 06/2006
1	Conditioned Culture MediaIBA 06/2006
1	Calcibiotic Root Canal SealerIBA 02/2002

Therapy/Procedure

12	Therapeutics 03/2022 - 05/2009
2	Endoscopes 01/2019 - 10/2015
1	Esophagectomy 03/2018
1	Drug Therapy (Chemotherapy) 08/2017
1	Retreatment 07/2017
1	Surgical Instruments (Clip) 01/2015
1	Decompression 01/2012